PDCD1 and melanoma: Both the cancer cell types (melanoma [27] and cholangiocarcinoma [28]) used here have previously been shown to release PD-L1 to stimulate PD-1 and cause T cell exhaustion, but PD-L1 has also been shown to be released from tumour associated macrophages [29].